• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗SSA/Ro 52-kD抗体阳性孕妇的胎儿中有三分之一会出现一度心脏传导阻滞的体征。

Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.

作者信息

Sonesson Sven-Erik, Salomonsson Stina, Jacobsson Lilly-Ann, Bremme Katarina, Wahren-Herlenius Marie

机构信息

Karolinska Institutet, Stockholm, Sweden.

出版信息

Arthritis Rheum. 2004 Apr;50(4):1253-61. doi: 10.1002/art.20126.

DOI:10.1002/art.20126
PMID:15077309
Abstract

OBJECTIVE

To prospectively investigate the development of fetal heart block in anti-SSA/Ro 52-kd-positive women, and to evaluate the usefulness of serial Doppler echocardiography in detecting early signs of congenital heart block.

METHODS

Twenty-four women with anti-SSA/Ro 52-kd antibodies and consequently increased risk for fetal heart block were followed up weekly, between 18 and 24 weeks of gestation, with two Doppler echocardiographic methods designed to estimate the time delay between hemodynamic events caused by atrial and ventricular depolarizations. Two hundred eighty-four women with normal pregnancies served as controls. Anti-Ro 52-kd, anti-Ro 60-kd, and anti-La antibodies were investigated by immunoblotting and enzyme-linked immunosorbent assay using recombinant proteins.

RESULTS

In anti-Ro 52-kd-positive women, fetal atrioventricular (AV) time intervals were longer and heart rates were slightly lower compared with those in controls. Eight of 24 fetuses had signs of first-degree block. One of these fetuses had progression to complete block, and another showed recovery from second-degree block to first-degree block with betamethasone treatment. In the remaining 6 fetuses, spontaneous normalization occurred before or shortly after birth. Fetuses with normal AV time intervals at 18-24 weeks had normal electrocardiographic results at birth.

CONCLUSION

Anti-Ro 52-kd-positive pregnant women frequently carry fetuses with Doppler echocardiographic signs of first-degree AV block. These blocks revert spontaneously in the majority of fetuses, but progression to a more severe degree of block may occur in some. Serial Doppler echocardiographic measurement of AV time intervals is suggested as a useful method for surveillance of these high-risk pregnancies.

摘要

目的

前瞻性研究抗SSA/Ro 52-kd抗体阳性女性胎儿心脏传导阻滞的发生情况,并评估连续多普勒超声心动图在检测先天性心脏传导阻滞早期征象中的作用。

方法

24例抗SSA/Ro 52-kd抗体阳性且胎儿心脏传导阻滞风险增加的女性,在妊娠18至24周期间每周进行随访,采用两种多普勒超声心动图方法评估心房和心室去极化引起的血流动力学事件之间的时间延迟。284例正常妊娠女性作为对照。使用重组蛋白通过免疫印迹法和酶联免疫吸附测定法检测抗Ro 52-kd、抗Ro 60-kd和抗La抗体。

结果

与对照组相比,抗Ro 52-kd抗体阳性女性胎儿的房室(AV)时间间期更长,心率略低。24例胎儿中有8例有一度传导阻滞的征象。其中1例胎儿进展为完全性传导阻滞,另一例在倍他米松治疗后从二度传导阻滞恢复为一度传导阻滞。其余6例胎儿在出生前或出生后不久自发恢复正常。在18至24周时AV时间间期正常的胎儿出生时心电图结果正常。

结论

抗Ro 52-kd抗体阳性孕妇所怀胎儿常出现多普勒超声心动图一度房室传导阻滞征象。这些传导阻滞在大多数胎儿中可自发恢复,但部分胎儿可能进展为更严重的传导阻滞。建议连续多普勒超声心动图测量AV时间间期作为监测这些高危妊娠的有用方法。

相似文献

1
Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.抗SSA/Ro 52-kD抗体阳性孕妇的胎儿中有三分之一会出现一度心脏传导阻滞的体征。
Arthritis Rheum. 2004 Apr;50(4):1253-61. doi: 10.1002/art.20126.
2
Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.胎儿暴露于与心脏传导阻滞相关的母体抗Ro52/SSA自身抗体的婴儿的结局与生长情况。
Pediatrics. 2008 Apr;121(4):e803-9. doi: 10.1542/peds.2007-1659.
3
Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance.抗 Ro52/SSA 抗体暴露的胎儿出现房室时间延长,提示心功能下降。
Ultrasound Obstet Gynecol. 2009 Nov;34(5):543-9. doi: 10.1002/uog.7343.
4
Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.预防患有抗SSA/Ro和抗SSB/La自身抗体的母亲所生儿童发生完全性心脏传导阻滞:一度房室传导阻滞的检测与治疗
Curr Opin Rheumatol. 2009 Sep;21(5):478-82. doi: 10.1097/BOR.0b013e32832ed817.
5
Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.影响抗 Ro/SSA 阳性妊娠胎儿心脏传导的因素。
Rheumatology (Oxford). 2017 Oct 1;56(10):1755-1762. doi: 10.1093/rheumatology/kex263.
6
The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.母体抗 Ro/SSA 抗体水平作为心脏新生儿狼疮红斑狼疮发生的预后标志物的重要性:一项对 186 例抗体暴露胎儿和婴儿的前瞻性研究。
J Am Coll Cardiol. 2010 Jun 15;55(24):2778-84. doi: 10.1016/j.jacc.2010.02.042.
7
Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.暴露于母体抗SSA/Ro-SSB/La抗体的胎儿房室传导阻滞的早期诊断与治疗:一项基于胎儿动态心电图的前瞻性观察研究。
Circulation. 2009 Apr 14;119(14):1867-72. doi: 10.1161/CIRCULATIONAHA.108.773143. Epub 2009 Mar 30.
8
Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.抗Ro/SSA阳性孕妇的产科和围产期结局:一项前瞻性队列研究。
Immunol Res. 2017 Apr;65(2):487-494. doi: 10.1007/s12026-016-8888-5.
9
Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.低滴度、孤立的抗Ro/SSA 60kd抗体与有先天性心脏传导阻滞风险的女性的良好妊娠结局相关。
Clin Rheumatol. 2017 May;36(5):1155-1160. doi: 10.1007/s10067-017-3572-2. Epub 2017 Feb 15.
10
Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.先天性心脏传导阻滞风险胎儿心脏监测的效用:PR间期与地塞米松评估(PRIDE)前瞻性研究
Circulation. 2008 Jan 29;117(4):485-93. doi: 10.1161/CIRCULATIONAHA.107.707661. Epub 2008 Jan 14.

引用本文的文献

1
Effects of maternal anti-Ro/La antibodies on fetal atrioventricular conduction evaluated with echocardiography: a state-of-the-art review.超声心动图评估母体抗Ro/La抗体对胎儿房室传导的影响:最新综述
Arch Gynecol Obstet. 2025 Jun 11. doi: 10.1007/s00404-025-08092-6.
2
Impact of early detection and steroid treatment on fetal ventricular heart rate and pacemaker implantation in anti-Ro/SSA positive congenital heart block.早期检测和类固醇治疗对抗Ro/SSA阳性先天性心脏传导阻滞胎儿心室心率及起搏器植入的影响
Acta Obstet Gynecol Scand. 2024 Dec;103(12):2433-2441. doi: 10.1111/aogs.14988. Epub 2024 Oct 9.
3
Prevalence of neonatal lupus in a small group of antibody-carrying mothers and frequency of complete atrioventricular block.
一小部分携带抗体的母亲所患新生儿狼疮的流行情况和完全性房室传导阻滞的发生频率。
Arch Cardiol Mex. 2024;94(1):33-38. doi: 10.24875/ACM.22000233.
4
Autoimmune congenital heart block: a case report and review of the literature related to pathogenesis and pregnancy management.自身免疫性先天性心脏传导阻滞:病例报告并复习相关发病机制和妊娠管理的文献。
Arthritis Res Ther. 2024 Jan 2;26(1):8. doi: 10.1186/s13075-023-03246-w.
5
Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis.抗 SSA/RO 抗体相关妊娠的母婴结局:系统评价和荟萃分析。
Pediatr Rheumatol Online J. 2023 Mar 4;21(1):22. doi: 10.1186/s12969-023-00803-0.
6
Short and long-term outcomes of children with autoimmune congenital heart block treated with a combined maternal-neonatal therapy. A comparison study.采用母婴联合治疗的自身免疫性先天性心脏传导阻滞患儿的短期和长期结局。一项比较研究。
J Perinatol. 2022 Sep;42(9):1161-1168. doi: 10.1038/s41372-022-01431-4. Epub 2022 Jun 18.
7
Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function.辅助蛋白是先天性心脏传导阻滞的一个新的易感基因,直接影响胎儿的心脏功能。
Ann Rheum Dis. 2022 Aug;81(8):1151-1161. doi: 10.1136/annrheumdis-2021-221714. Epub 2022 Apr 25.
8
An Overview of Neonatal Lupus with Anti-Ro Characteristics.抗 Ro 抗体相关新生儿狼疮概述。
Int J Mol Sci. 2021 Aug 27;22(17):9281. doi: 10.3390/ijms22179281.
9
Congenital Heart Disease: An Immunological Perspective.先天性心脏病:免疫学视角
Front Cardiovasc Med. 2021 Aug 9;8:701375. doi: 10.3389/fcvm.2021.701375. eCollection 2021.
10
Case Report: Prenatal Diagnosis and Treatment of Fetal Autoimmune-Associated First-Degree Atrioventricular Block: First Report From China.病例报告:胎儿自身免疫性相关一度房室传导阻滞的产前诊断与治疗:来自中国的首例报告
Front Cardiovasc Med. 2021 Jun 21;8:683486. doi: 10.3389/fcvm.2021.683486. eCollection 2021.